On June 8, 2026, Jaguar Health, Inc. secured a $40 million equity line of credit agreement with an investor, allowing for stock purchases based on specific price conditions. Additionally, the company raised $2 million through preferred stock financing by issuing 240 shares of Series P Non-Convertible Preferred Stock.